Sign up
Log in
ENvue Medical names Zeev Rotstein board chairman as David Johnson exits
Share
Listen to the news
ENvue Medical names Zeev Rotstein board chairman as David Johnson exits
  • Envue Medical named Zeev Rotstein chairman, replacing David Johnson, who is leaving the board; director Nino Pionati also departs.
  • Rotstein previously spent 36 years at Sheba Medical Center, including 12 years as director general; later led Hadassah Medical Center as CEO.
  • Zvi Joseph joined the board; he is head of AI Governance, Risk & Compliance at Amdocs, following two decades as deputy general counsel.
  • Lior Buchman joined the board; he is fractional CFO at ERBProximo, previously CFO at Orpheus Medical and Sightline Technologies.
  • Buchman has executed more than $320 million in financings and M&A, adding capital markets experience as the company advances its navigation platform.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envue Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607150800PRIMZONEFULLFEED9762357) on July 15, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.